Cargando…
The Evolving Role of (18)F-FDG PET/CT in Diagnosis and Prognosis Prediction in Progressive Prostate Cancer
Positron emission tomography/computed tomography (PET/CT) is widely used in prostate cancer to evaluate the localized tumor burden and detect symptomatic metastatic lesions early. (18)F-FDG is the most used tracer for oncologic imaging, but it has limitations in detecting early-stage prostate cancer...
Autores principales: | Shen, Kai, Liu, Bo, Zhou, Xiang, Ji, Yiyi, Chen, Lei, Wang, Qi, Xue, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358601/ https://www.ncbi.nlm.nih.gov/pubmed/34395251 http://dx.doi.org/10.3389/fonc.2021.683793 |
Ejemplares similares
-
Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019) -
[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023) -
Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022) -
Peritoneal Mouse as Detected on (18)F-FDG PET-CT
por: Allam, Talha, et al.
Publicado: (2013) -
Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
por: Zhou, Xing, et al.
Publicado: (2021)